The RISK21 v2.0 public-private Scientific Advisory Board (SAB) and ad-hoc advisors is comprised of leading experts in risk assessment and related disciplines. This Advisory team is tasked with developing a strategic plan to support the overall program goals.
Science Advisory Board
- Michelle Embry (HESI)
- Jon Arnot (ARC)
- Juliana Braz (Brazilian Health Regulatory Agency - ANVISA)
- Sandrine Deglin (HESI)
- Suzanne Hartigan (American Chemistry Council)
- Haitian Lu (Syngenta)
- Camila Oueiroz Moreira (Brazilian Health Regulatory Agency - ANVISA)
- Angelo Moretto (U of Milan)
- Eliana Munarriz (U of Buenos Aires)
- Claire Terry (Corteva)
- Maria Trainer (Australian Pesticides and Veterinary Medicines Authority)
- Marcelo Wolansky (U of Buenos Aires)
- Doug Wolf (Syngenta)
- Steven Zou (ExxonMobil)
Ad-hoc Advisors
- Tara Barton-McClaren (Health Canada)
- Gino Scarano (USEPA)
- Zuzana Kloslova (ECHA)
- Angelika Zidek (Health Canada)